Economic implications of osteoporosis-related femoral fractures in Saudi Arabian Society

Calcified Tissue International

Volumn 81, Issue 6, 2007, Pages 455-458

  Bubshait, Dalal ^a   Sadat Ali, Mir ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Economic costs; Femur; Fracture; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; FEMUR FRACTURE; FRAGILITY FRACTURE; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAUDI ARABIA;

AGED; AGED, 80 AND OVER; FEMALE; FEMORAL FRACTURES; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; SAUDI ARABIA;

EID: 37548999837     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-007-9090-5     Document Type: Article

References (28)

1. Glaser DL, Kaplan FS (1997) Osteoporosis: Definition and clinical presentation. Spine 22:12S-16S
2. Sadat-Ali M, Al Elq A (2006) Osteoporosis among male saudi arabs: A pilot study. Ann Saudi Med 26:450-454
3. Ardawi MSM, Maimany AA, Bahksh TM, Nasrat HAN, Milaat WA, Al-Raddadi RM (2005) Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int 16:43-55
4. Sadat-Ali M, Al-Habdan I, Al-Mulhim FA, El-Hassan AY (2005) Effect of parity on bone mineral density among postmenopausal Saudi Arabian women. Saudi Med J 26:1588-1590
5. Sadat-Ali M, Al-Habdan I, Al-Mulhim FA, El-Hassan AY (2004) Bone mineral density among postmenopausal Saudi women. Saudi Med J 25:1623-1625
6. Sadat-Ali-M, Al-Habdan I, Marwah S (1996) Bone mineral density measurement of distal radius in Saudi Arabian females. Ann Saudi Med 16:414-416
7. El-Desouki M (2003) Osteoporosis in postmenopausal Saudi women using dual X-ray bone densitometry. Saudi Med J 24:953-956
8. Pentek M, Horvath C, Bonez I, Falusi Z, Toth E, Sebestyen A, et al. (2007) Epidemiology of osteoporosis-related fractures in Hungary from the nationwide health insurance database 1999-2003. Osteoporosis Int Aug 16, 2007 [Epub ahead of print]
9. Marin F, Gonzalez-Macias J, Moya R, Onrubia C, Cancelo C, Alvarez S, et al. (2006) Fragility non-spinal fractures in a cohort of 5,201 women aged 65 years and older during a 3 year follow-up. Med Clin (Barc) 127:401-404
10. Al-Nuaim AR, Kremli M, Al-Nuaim M, Sandkgi S (1995) Incidence of proximal femur fracture in an urbanized community in Saudi Arabia. Calcif Tissue Int 56:536-538
11. Baddoura R (2001) Incidence of hip fractures in the Lebanese population. East Meiterr Health J 7:725-729
12. Memon A, Pospula WM, Tantawy AY, Abdul-Gaffar S, Suresh A, Al-Rowaih A (1998) Incidence of hip fracture in Kuwait. Int J Epidemiol 27:860-865
13. Sadat-Ali M, Gullenpet AH, Al-Mulhim F, Al-Turki H, Al-Shammary H, Al-Elq A, et al. (2007) Osteoporosis-related vertebral fractures: Its prevalence in the Saudi Arabian society. East Mediterr Health J (in press)
14. ICD (1998) International classification of diseases, 9th revision; clinical modification, 6th edn. http://www.cdc.gov/nchs/datawh
15. Sadat-Ali M (2006) Assessment of femoral fractures in eastern province of Saudi Arabia. Personal communication
16. http://www.ministryplanning.com.sa
17. SPSS (2007) SPSS statistical software package, version 14.0. Chicago, IL: SPSS
18. Wicktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadinitropoulos E (2001) Economic implications of hip fracture: Health service use, institutional care and Cost in Canada. Osteoporos Int 12:271-278
19. Brainsky A, Glick H, Lydick E, Epstein R, Fox KM, Hawkes W, Kashner TM (1997) Dwelling older adults: A prospective study. J Am Geriatr Soc 45:281-287
20. Lawrence TM, White CT, Wenn R, Moran CG (2005) The current hospital costs of treating hip fractures. Injury 36:88-91
21. Burge RT, Dawson-Hughes B, King AB, Solomon DH, Tosteson A, Wong JB (2005) Incidence and economic burden of osteoporotic fractures in the United States, 2005-2025. http://www.nof.confex.com/nof/2005/techprogram/P400.HTM
22. National Institute for Health and Clinical Excellence (NICE) (2005) Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Technology appraisal 87. NICE, London
23. King AB, Saag KG, Burge RT, Pisu M, Goel N (2005) Fracture reduction affects Medicare economics (FRAME): Impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 16:1545-1557
24. Diez-Perez A, Puig MJ, Martinez IMT, Guelar GAM, Cucurull CJ, Mellibovsky SL, et al. (1989) Estimate of the costs of osteoporotic fractures of the femur in Spain. Med Clin (Barc) 92:721-723
25. Nguyen ND, Eisman JA, Nguyen TV (2006) Anti-hip fracture efficacy of biophosphonates: A Bayesian analysis of clinical trials. J Bone Miner Res 21:340-349
26. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski J, Spector T, et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-468
27. Chesnut CC III, et al. (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: Results from the BONE study. Osteoporos Int 15:792-798
28. Thomas ML, Christopher TW, Russell W, Christopher GM (2005) The current hospital cost of treating hip fractures. Injury 36:88-91